Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
Agensys, an Affiliate of Astellas, Announces Initiation of Phase I Clinical Trial of AGS-16M8F for Renal Cancer
Agensys, Inc., an affiliate of Tokyo-based Astellas Pharma Inc., today announced that they have initiated a Phase I clinical trial of AGS-16M8F an antibody-drug conjugate that is being developed for the treatment of metastatic renal cancer.
Read more on PR Newswire via Yahoo! Finance
Categories: Breast Cancer Treatment Tags: affiliate, Agensys, AGS16M8F, Announces, Astellas, cancer, Clinical, initiation, Phase, Renal, Trial
OSI Bid Likely to Rise as Astellas Seeks Cancer Sales (Update3)
OSI Bid Likely to Rise as Astellas Seeks Cancer Sales (Update3)
March 9 (Bloomberg) — OSI Pharmaceuticals Inc .’s status as one of the few U.S. biotechnology companies with income from an approved cancer drug likely will drive up the price Tokyo-based Astellas Pharma Inc.
Read more on Bloomberg
OSI Bid Likely to Rise as Astellas Seeks Cancer Sales
OSI Bid Likely to Rise as Astellas Seeks Cancer Sales
March 9 (Bloomberg) — OSI Pharmaceuticals Inc.’s status as one of the few U.S. biotechnology companies with income from an approved cancer drug likely will drive up the price Tokyo-based Astell…
Read more on MalaysiaNews.net